Fritextsökning
Innehållstyper
-
USA vill öka transparensen
Vill ändra lagstiftningen för öka mängden tillgänglig information från kliniska studier.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Tar in 445 miljoner
Det preliminära utfallet av Aerocrines genomförda emission visar att den blev övertecknad.
-
Karin Meyer lämnar PCG
Karin Meyer går till nytt jobb.
-
Här odlar forskarna minihjärnor
Genom att odla hjärnsubstans vill österrikiska forskare revolutionera forskningen inom neurosjukdomar, läkemedelsutveckling och samtidigt ersätta djurförsök.
-
Tar fram infrastruktur för metabolomik
Uppsala universitet är en del i ett konsortium som utvecklar en infrastruktur för forskning på metabolomet och genomet.
-
Biovitrum får orphan drug-status i EU
Färre behandlingstillfällen för blödarsjuka är i sikte med Swedish Orphan Biovitrums läkemedelskandidat. Nu kan läkemedlet nå den europeiska marknaden fortare.
-
Density meters with six-digit precision
The new instruments from Krüss Optronic offer high sensitivity for density measurements.
-
Hoppas på Kina
Förändringarna i Kinas enbarnspolitik kan ha en positiv påverkan på försäljningen av fertilitetsprodukter tror Vitrolife, som har ökat sitt resultat genom förvärv.
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Framåt för Sobi
Ökar intäkterna och inväntar godkännande av hemofililäkemedlet Elocta.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Hormones make children fat
A new Danish million project will define the connection between hormons and obesity amongst children.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
BREAKING